<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Middle East respiratory syndrome coronavirus: Clinical manifestations and diagnosis</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Middle East respiratory syndrome coronavirus: Clinical manifestations and diagnosis</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Middle East respiratory syndrome coronavirus: Clinical manifestations and diagnosis</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Kenneth McIntosh, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Martin S Hirsch, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Allyson Bloom, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jan 17, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H3818971095"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>In September 2012, a case of novel coronavirus infection was reported involving a man in Saudi Arabia who was admitted to a hospital with pneumonia and acute kidney injury in June 2012 [<a href="#rid1">1</a>]. Only a few days later, a separate report appeared of an almost identical virus detected in a second patient with acute respiratory syndrome and acute kidney injury [<a href="#rid2">2,3</a>]. The second patient initially developed symptoms in Qatar but had traveled to Saudi Arabia before he became ill and then sought care in the United Kingdom [<a href="#rid4">4</a>]. Many subsequent cases and clusters of infections have been reported [<a href="#rid5">5</a>].</p><p>This novel coronavirus, initially termed human coronavirus-EMC (for Erasmus Medical Center), has been named Middle East respiratory syndrome coronavirus (MERS-CoV) [<a href="#rid6">6</a>].</p><p>Updated information about MERS-CoV can be found on the <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.who.int%2Fhealth-topics%2Fmiddle-east-respiratory-syndrome-coronavirus-mers%23tab%3Dtab_1&amp;token=%2FPi1VLB9%2BfHsXlMtDZzxAbI5gdR%2FzRnOgz42K%2FJDpD9STtBJXXEOEo3Bwzg3uFxMHGhhPh7vvpTLbblcEAu3ki10n%2BpvnrmMRNMpCMcRzx5V28Nktvhr1giztMlF4WOy&amp;TOPIC_ID=106589" target="_blank">World Health Organization's website</a> and the <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.cdc.gov%2Fcoronavirus%2Fmers%2Findex.html&amp;token=R4Uiw8%2FbmPVaqNHRDqpXLETVYV9fJcW0p5%2FSZ3txP%2BFbcePMPPOiI3FXSckc6d4vCKD86AbmnZK0tsD4HZ1lxQ%3D%3D&amp;TOPIC_ID=106589" target="_blank">United States Centers for Disease Control and Prevention's website</a>.</p><p>The clinical manifestations and diagnosis of MERS-CoV are discussed here. The virology, epidemiology, treatment, and prevention of MERS-CoV are discussed separately. Community-acquired coronaviruses and severe acute respiratory syndrome coronavirus are also reviewed separately. (See  <a class="medical medical_review" href="/d/html/89705.html" rel="external">"Middle East respiratory syndrome coronavirus: Virology, pathogenesis, and epidemiology"</a> and  <a class="medical medical_review" href="/d/html/106550.html" rel="external">"Middle East respiratory syndrome coronavirus: Treatment and prevention"</a> and  <a class="medical medical_review" href="/d/html/8298.html" rel="external">"Coronaviruses"</a> and  <a class="medical medical_review" href="/d/html/3027.html" rel="external">"Severe acute respiratory syndrome (SARS)"</a>.)</p><p class="headingAnchor" id="H730349197"><span class="h1">CASE DEFINITIONS</span><span class="headingEndMark"> — </span>For epidemiologic purposes, the following Middle East respiratory syndrome coronavirus (MERS-CoV) infection case definitions have been proposed by the World Health Organization (WHO) [<a href="#rid7">7</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Confirmed case</strong> – A person with laboratory confirmation of infection with MERS-CoV irrespective of clinical signs and symptoms</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Probable case</strong> – A probable case is defined by the following criteria:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>A febrile acute respiratory illness with clinical, radiographic, or histopathologic evidence of pulmonary parenchymal disease (eg, pneumonia or acute respiratory distress syndrome) <strong>and</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>A direct epidemiologic link with a laboratory-confirmed MERS-CoV case <strong>and</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Testing for MERS-CoV is unavailable, negative on a single inadequate specimen, or inconclusive</p><p></p><p class="bulletIndent1"><strong>OR</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>A febrile acute respiratory illness with clinical, radiographic, or histopathologic evidence of pulmonary parenchymal disease (eg, pneumonia or acute respiratory distress syndrome) that cannot be explained fully by any other etiology; <strong>and</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>The person resides in or traveled to the Middle East or countries where MERS-CoV is known to be circulating in dromedary camels or where human infections have recently occurred <strong>and</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Testing for MERS-CoV is inconclusive</p><p></p><p class="bulletIndent1"><strong>OR</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>An acute febrile respiratory illness of any severity <strong>and</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Direct epidemiologic link with a confirmed MERS-CoV case <strong>and</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Testing for MERS-CoV is inconclusive</p><p></p><p>WHO criteria for laboratory confirmation require detection of viral nucleic acid or acute and convalescent serology. The presence of nucleic acid can be confirmed by positive results from at least two sequence-specific real-time reverse-transcriptase polymerase chain reactions (rRT-PCRs) or a single sequence-specific rRT-PCR test and direct sequencing from a separate genomic target [<a href="#rid8">8</a>]. A case confirmed by serology requires demonstration of seroconversion in two samples ideally collected at least 14 days apart using at least one screening assay (enzyme-linked immunoassay, immunofluorescence assay) and a neutralization assay. PCR testing is discussed in detail below. (See <a class="local">'Polymerase chain reaction and sequencing'</a> below.)</p><p>The United States Centers for Disease Control and Prevention's (CDC's) case definitions can be found on the <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.cdc.gov%2Fcoronavirus%2Fmers%2Fcase-def.html&amp;token=R4Uiw8%2FbmPVaqNHRDqpXLETVYV9fJcW0p5%2FSZ3txP%2BECZLdzgaiR9u9WLARD7xO1EbbOTG7JZlCD0fl9M%2FDHZQ%3D%3D&amp;TOPIC_ID=106589" target="_blank">CDC's website</a>.</p><p class="headingAnchor" id="H2924446397"><span class="h1">CLINICAL MANIFESTATIONS</span></p><p class="headingAnchor" id="H3776417820"><span class="h2">Incubation period</span><span class="headingEndMark"> — </span>In an outbreak of Middle East respiratory syndrome coronavirus (MERS-CoV) infection in Saudi Arabia that resulted in laboratory-confirmed MERS-CoV in 23 individuals, the median incubation period was 5.2 days (95% CI 1.9-14.7 days) [<a href="#rid9">9</a>]. In one secondary case that occurred in a patient in France who shared a room with an infected patient, the incubation period was estimated at 9 to 12 days [<a href="#rid10">10</a>]. In the 2015 outbreak in South Korea, the median incubation period was 6.3 days (95th percentile 12.1 days) [<a href="#rid11">11</a>]. The longer incubation period in South Korea was also observed in a later combined analysis, which calculated means of 5.0 days (95% CI 4.0 to 6.6) for Saudi Arabia (34 cases) versus 6.9 days (95% CI 6.3 to 7.5) for South Korea (115 cases) [<a href="#rid12">12</a>]. This finding is unexplained but could be due to factors related to the differences in data sources or, possibly, evolution in the virus itself.</p><p>The World Health Organization (WHO) and the United States Centers for Disease Control and Prevention (CDC) recommend that an evaluation for MERS-CoV be considered in individuals with a syndrome of MERS who returned from travel to the Arabian peninsula or neighboring countries within the past 14 days [<a href="#rid13">13</a>]. Countries in or neighboring the Arabian Peninsula are defined below. (See <a class="local">'In the United States'</a> below.)</p><p class="headingAnchor" id="H3352663212"><span class="h2">Clinical features</span></p><p class="headingAnchor" id="H1304043858"><span class="h3">Signs and symptoms</span><span class="headingEndMark"> — </span>Most reported patients with MERS-CoV infection have been adults with severe pneumonia and acute respiratory distress syndrome, and some have had acute kidney injury [<a href="#rid4">4,9,10,14-20</a>]. Many patients have required mechanical ventilation, and some have required extracorporeal membrane oxygenation. </p><p>Other clinical manifestations that have been reported are gastrointestinal symptoms (anorexia, nausea, vomiting, abdominal pain, diarrhea), pericarditis, and disseminated intravascular coagulation [<a href="#rid10">10,14,15,17,21</a>]. Among 12 critically ill patients, 11 had extrapulmonary manifestations including shock (in 11) and acute kidney injury (in 7) [<a href="#rid18">18</a>]. Two patients have been reported who presented with diarrhea, one of whom was immunocompromised [<a href="#rid22">22</a>]. In both cases, chest radiography revealed pneumonia and the correct diagnosis was made. One immunocompromised patient presented with fever, diarrhea, and abdominal pain but without early respiratory symptoms; pneumonia was identified incidentally on a chest radiograph [<a href="#rid10">10,15</a>]. Three adults with pneumonia and MERS-CoV infection also developed neurologic symptoms and showed widespread intracranial white matter lesions by magnetic resonance imaging [<a href="#rid23">23</a>].</p><p>The following clinical findings were observed among 47 patients with MERS-CoV infection in Saudi Arabia [<a href="#rid17">17</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Fever (&gt;38°C) – 46 patients (98 percent)</p><p class="bulletIndent1"><span class="glyph">●</span>Fever with chills or rigors – 41 patients (87 percent)</p><p class="bulletIndent1"><span class="glyph">●</span>Cough – 39 patients (83 percent)</p><p class="bulletIndent1"><span class="glyph">●</span>Shortness of breath – 34 patients (72 percent)</p><p class="bulletIndent1"><span class="glyph">●</span>Hemoptysis – 8 patients (17 percent)</p><p class="bulletIndent1"><span class="glyph">●</span>Sore throat – 10 patients (21 percent)</p><p class="bulletIndent1"><span class="glyph">●</span>Myalgias – 15 patients (32 percent)</p><p class="bulletIndent1"><span class="glyph">●</span>Diarrhea – 12 patients (26 percent)</p><p class="bulletIndent1"><span class="glyph">●</span>Vomiting – 10 patients (21 percent)</p><p class="bulletIndent1"><span class="glyph">●</span>Abdominal pain – 8 patients (17 percent)</p><p class="bulletIndent1"><span class="glyph">●</span>Abnormal chest radiograph – 47 patients (100 percent)</p><p></p><p>Of these 47 patients, 42 (89 percent) required intensive care and 34 (72 percent) required mechanical ventilation [<a href="#rid17">17</a>]. The median time from presentation for medical care to mechanical ventilation was 7 days (range 3 to 11 days) and to death was 14 days (range 5 to 36 days). A comparison of 330 critically ill MERS patients with 222 critically ill non-MERS patients in 14 Saudi Arabian hospitals over a single time period indicated several differences [<a href="#rid20">20</a>]. MERS patients were somewhat younger, more often mechanically ventilated, and had higher mortality but also showed considerable overlap in clinical features and comorbidities, emphasizing the importance of specific and rapid diagnosis for optimal management, infection control, and prognosis.</p><p>Outcomes are discussed in greater detail separately. (See  <a class="medical medical_review" href="/d/html/106550.html" rel="external">"Middle East respiratory syndrome coronavirus: Treatment and prevention", section on 'Prognosis'</a>.)</p><p class="headingAnchor" id="H826942234"><span class="h3">Mild and asymptomatic infections</span><span class="headingEndMark"> — </span>Although many patients have had severe disease, some reports have described individuals with a mild respiratory illness not requiring hospitalization [<a href="#rid13">13,24</a>]. In one report, a patient developed a dry cough on the 10<sup>th</sup> day of illness followed by dyspnea and hypoxia on the 11<sup>th</sup> day of illness; prior to that, he had only nonspecific signs and symptoms (malaise, myalgias, low-grade fever) [<a href="#rid25">25</a>].</p><p>Several individuals with asymptomatic infection have been identified among contacts of patients with symptomatic infection [<a href="#rid24">24,26-28</a>]. As an example, the Saudi Arabian Ministry of Health screened more than 3000 close contacts of patients using real-time reverse-transcriptase polymerase chain reaction of nasopharyngeal swabs and identified seven healthcare workers with MERS-CoV infection, two of whom were asymptomatic and five of whom had mild upper respiratory tract symptoms [<a href="#rid24">24</a>]. A study that modeled clinical data from active versus passive surveillance estimated that the ratio of symptomatic to total infections was strongly age related, rising from 11 percent in those under 20 years of age to 88 percent in those 70 years old or older, with a parallel rise in the case-fatality ratio [<a href="#rid29">29</a>].</p><p>It appears that many individuals who have been reported to be asymptomatic have in fact had signs and symptoms of illness. In a study of a healthcare facility–associated outbreak in Jeddah, Saudi Arabia, in the spring of 2014, there were 255 laboratory-confirmed cases of MERS-CoV infection [<a href="#rid27">27</a>]. Of 64 patients who were initially identified as being asymptomatic, 33 of the 64 individuals (52 percent) were available for a telephone survey. Of these 33 people, 79 percent reported at least one symptom during the month before testing and 70 percent reported more than one symptom. Unexpectedly, 36 percent of the individuals reported the presence of signs and symptoms as the reason for undergoing MERS-CoV testing, even though they had been identified as being asymptomatic.</p><p>However, one report describes asymptomatic infection in two men who had contact with infected dromedary camels and who were identified by active surveillance [<a href="#rid30">30</a>]. Both men were hospitalized for observation for approximately two incubation periods and remained asymptomatic.</p><p class="headingAnchor" id="H731888010"><span class="h3">Children</span><span class="headingEndMark"> — </span>A report of pediatric cases describes 31 MERS-CoV infections in children between 9 months and 17 years of age [<a href="#rid31">31</a>]. Most were discovered in surveys performed among contacts of known cases using PCR of upper respiratory tract samples. Of 29 cases for which some clinical data were available, 13 were asymptomatic. Of 14 children with outcome information, 2 died, one a 2-year-old child with cystic fibrosis [<a href="#rid32">32</a>] and one a 9-month-old with congenital nephrotic syndrome [<a href="#rid33">33</a>]. One other, a 14-year-old girl with Down syndrome, was hospitalized and recovered [<a href="#rid32">32</a>].</p><p class="headingAnchor" id="H202458251"><span class="h3">Effect on pregnant women and fetuses</span><span class="headingEndMark"> — </span>As of 2019, a total of 11 cases of MERS-CoV infection during pregnancy have been reported [<a href="#rid34">34,35</a>]. These included three maternal deaths and three infant deaths. One woman with MERS-CoV developed vaginal bleeding and abdominal pain on the seventh day of illness and spontaneously delivered a stillborn infant at five months gestation [<a href="#rid36">36</a>]. Two other case reports describe severe maternal disease in the third trimester, one of whom died and both of whom delivered apparently uninfected and healthy preterm infants [<a href="#rid37">37,38</a>]. Five additional cases have been reported in pregnant women; outcomes included one stillbirth at 34 weeks, one maternal death from severe pneumonia 19 days after delivery of a healthy infant, one premature delivery with death of both mother and infant, and two episodes of moderately severe pneumonia in the mother with subsequent recovery and deliveries of healthy infants [<a href="#rid39">39</a>]. In three additional cases, both mothers and infants survived [<a href="#rid40">40,41</a>].</p><p class="headingAnchor" id="H379676007"><span class="h2">Laboratory abnormalities</span><span class="headingEndMark"> — </span>Among 47 cases of MERS-CoV infection in Saudi Arabia, laboratory abnormalities included leukopenia (14 percent), lymphopenia (34 percent), lymphocytosis (11 percent), thrombocytopenia (36 percent), elevated aspartate aminotransferase (15 percent), elevated alanine aminotransferase (11 percent), and elevated lactate dehydrogenase (49 percent) [<a href="#rid17">17</a>]. Other reports have described lymphocytopenia (with or without neutropenia), anemia, and/or thrombocytopenia [<a href="#rid10">10,14,16,18</a>]. Some patients have shown progressive renal failure, with rising blood urea nitrogen and creatinine [<a href="#rid4">4,10,14,18,42</a>]. Disseminated intravascular coagulation and hemolysis have also been reported [<a href="#rid15">15,16</a>].</p><p class="headingAnchor" id="H3130954355"><span class="h2">Imaging findings</span><span class="headingEndMark"> — </span>As noted above, among 47 cases of MERS-CoV disease in Saudi Arabia, abnormalities on chest radiography were noted in all 47 cases [<a href="#rid17">17</a>]. Imaging findings ranged from minimal to extensive abnormalities, including increased bronchovascular markings, airspace opacities, patchy infiltrates, interstitial changes, patchy to confluent airspace consolidations, nodular opacities, reticular opacities, reticulonodular shadowing, pleural effusions, and total opacification of lung segments and lobes; abnormalities were either unilateral or bilateral (<a class="graphic graphic_diagnosticimage graphicRef90331" href="/d/graphic/90331.html" rel="external">image 1</a>). In another study, ground-glass opacity in a peripheral location was the most common abnormality observed on chest radiography [<a href="#rid43">43</a>].</p><p>In patients with MERS-CoV who underwent computed tomography scanning, the most common findings were bilateral predominantly peripheral and basilar airspace changes with more extensive ground-glass opacities than consolidation [<a href="#rid44">44-46</a>].</p><p class="headingAnchor" id="H1101759153"><span class="h1">COMORBIDITIES</span><span class="headingEndMark"> — </span>It remains unclear whether persons with specific comorbidities are disproportionately infected with Middle East respiratory syndrome coronavirus (MERS-CoV) or come to medical attention because they have more severe disease [<a href="#rid47">47</a>]. An early study of 47 patients with MERS-CoV infection in Saudi Arabia noted that 45 (96 percent) had underlying comorbidities, including diabetes mellitus, hypertension, chronic cardiac disease, chronic lung disease, and chronic kidney disease [<a href="#rid17">17</a>]. In a study of 12 critically ill patients with MERS-CoV infection, each individual had at least one comorbid condition; the median number of comorbid conditions was 3 (range 1 to 6) [<a href="#rid18">18</a>]. A meta-analysis of 12 series between 2013 and 2016 from the Middle East concluded that diabetes or hypertension was present in about one half of reported severe MERS cases, coronary or cardiovascular disease in 31 percent, and obesity in 16 percent [<a href="#rid48">48</a>]. The overall prevalence of comorbidities (ie, what proportion had at least one comorbidity) was not specified.</p><p>The high rate of comorbidities reported must be interpreted with caution, since diabetes mellitus was frequently observed in a study of more than 6000 patients presenting to an outpatient clinic in Riyadh, Saudi Arabia, and because approximately half of the 47 patients described in the first study were part of an outbreak in a hemodialysis unit [<a href="#rid17">17</a>], where rates of chronic kidney disease and hypertension would be expected to be high [<a href="#rid49">49</a>].</p><p>The most common comorbidities in the 2015 MERS outbreak in Korea (total number of cases, 186) were respiratory disorders and cancer (11 cases each), hypertension (8 cases), and cardiovascular diseases (5 cases). There were 4 cases of diabetes and none of chronic kidney disease [<a href="#rid50">50</a>]. It may be that the increased expression of DPP4 (the cellular receptor for MERS-CoV infection) found in both smokers and adults with chronic obstructive pulmonary disease plays a role in susceptibility to, as well as severity of, MERS [<a href="#rid51">51-53</a>].</p><p>The association between comorbidities and outcomes is discussed separately. (See  <a class="medical medical_review" href="/d/html/106550.html" rel="external">"Middle East respiratory syndrome coronavirus: Treatment and prevention", section on 'Prognosis'</a>.)</p><p class="headingAnchor" id="H2541928698"><span class="h1">OUTCOMES</span><span class="headingEndMark"> — </span>Mortality and other outcomes are discussed in detail elsewhere. (See  <a class="medical medical_review" href="/d/html/106550.html" rel="external">"Middle East respiratory syndrome coronavirus: Treatment and prevention", section on 'Prognosis'</a>.)</p><p class="headingAnchor" id="H2707356371"><span class="h1">DIAGNOSIS</span><span class="headingEndMark"> — </span>The World Health Organization (WHO) has developed a questionnaire to be used for the initial investigation of cases; it can be found on the <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fcdn.who.int%2Fmedia%2Fdocs%2Fdefault-source%2Fdocuments%2Femergencies%2Fhealth-topics---mers%2Fmers-case-investigation-questionnaire-v2.pdf%3Fsfvrsn%3D3f4f13e7_2&amp;token=Tc204B7g24zM0SK36ALNi9076%2B5MrTmtmzL1P0PXe4Cx%2Fn5aW8bKHG5QLROcyQ1uYhJTjPUHViTTGAR5EcqAgJY8B4qiJuS41IQCDojJSnMWMd3nyi%2BPoA81BDLxijl6y0PqN33nJm04epFJX5zXysDL5pggBJzEeehECprUeYM%3D&amp;TOPIC_ID=106589" target="_blank">WHO's website</a> [<a href="#rid54">54</a>].</p><p class="headingAnchor" id="H3762552922"><span class="h2">Preferred tests and specimen types</span><span class="headingEndMark"> — </span>Lower respiratory tract specimens should be the first priority for collection and real-time reverse-transcriptase polymerase chain reaction (rRT-PCR) testing, since rRT-PCR testing of lower respiratory specimens appears to be more sensitive for detection of Middle East respiratory syndrome coronavirus (MERS-CoV) than testing of upper respiratory tract specimens [<a href="#rid8">8,13,55,56</a>]. (See <a class="local">'Polymerase chain reaction and sequencing'</a> below.)</p><p>Given the potential severity of MERS-CoV infections, the risk for human-to-human transmission, and the limited data about the sensitivity of each diagnostic test, we suggest that multiple specimens be collected from different sites and at different times to increase the likelihood of detecting MERS-CoV [<a href="#rid8">8,55</a>]. Ideally, lower respiratory tract, upper respiratory tract, <strong>and</strong> serum samples should be obtained [<a href="#rid56">56</a>]. Priority should be given to respiratory specimens (lower tract if obtainable and in all cases of severe disease; upper tract if disease is mild and lower tract specimens cannot be obtained). A serum sample should also be obtained for serologic testing [<a href="#rid8">8,56</a>].</p><p>We recommend the following diagnostic approach, which has been adapted from guidelines issued by the United States Centers for Disease Control and Prevention (CDC) and the WHO [<a href="#rid8">8,55-57</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Lower respiratory tract specimens</strong> such as sputum, endotracheal aspirate, or bronchoalveolar lavage (BAL) fluid should be obtained for rRT-PCR testing from all cases of severe disease and from milder cases when possible.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Upper respiratory tract specimens</strong> should be obtained for rRT-PCR testing and should be either a combined nasopharyngeal and oropharyngeal swab specimen (two synthetic fiber swabs with plastic shafts, combined in a single collection container) <strong>or</strong> a 2 to 3 mL nasopharyngeal aspirate. Obtaining upper respiratory tract specimens is especially important if the patient does not have signs or symptoms of lower respiratory tract disease or if the collection of lower respiratory tract specimens is not possible.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>If initial testing of respiratory specimens is negative in a patient who is strongly suspected of having MERS-CoV infection, additional respiratory specimens should be obtained from multiple respiratory sites. Possible reasons for false-negative results include that the specimen was of poor quality, that it was collected late or very early in the illness, that it was not handled and shipped appropriately, or that there were technical problems with the test.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A <strong>serum sample</strong> (at least 0.2 mL of serum) should be obtained in the first 10 to 12 days after onset of illness for rRT-PCR, and a second serum sample (also at least 0.2 mL of serum) should be collected at least 14 days after onset of illness for antibody detection [<a href="#rid56">56</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In<em> </em>certain cases, the diagnosis should be confirmed by nucleic acid sequencing [<a href="#rid8">8</a>].</p><p></p><p>Repeat testing is helpful for confirming clearance of the virus. Respiratory specimens should be tested every two to four days until there are two consecutive negative results. If the discharge of the patient from an isolation ward requires negative PCR results, specimens can be obtained daily.</p><p>Laboratories with limited experience testing for MERS-CoV are encouraged to have their results confirmed by laboratories with greater experience (particularly negative specimens from patients in whom MERS-CoV infection is thought to be likely) [<a href="#rid8">8</a>].</p><p>Additional information about diagnostic testing can be found in a <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.who.int%2Fpublications%2Fi%2Fitem%2F10665-259952&amp;token=mr3MkQMxxRm373pPGLTYB%2B8L7rJeOJtqYOfpSLq18h4WQa1Ln%2Bu%2F4SIPBfMbWK7m%2FnxmBh60kmLsbqtSaWrkQQ%3D%3D&amp;TOPIC_ID=106589" target="_blank">WHO document</a> and in a <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.cdc.gov%2Fcoronavirus%2Fmers%2Fguidelines-clinical-specimens.html&amp;token=dWwaSuIy4cnlOkzFmU%2FcpO6fQgk6rnfC6wvJhBdfYFLAfosiCBeerdpxLXMeYD2ecpbx9%2BVsBMCROQXIsdu6IdqxidJ9GXJwSUVZZ%2BhYask%3D&amp;TOPIC_ID=106589" target="_blank">CDC document</a> [<a href="#rid8">8,56</a>].</p><p class="headingAnchor" id="H3414185774"><span class="h3">Polymerase chain reaction and sequencing</span><span class="headingEndMark"> — </span>Data from the cases sampled to date indicate that lower respiratory tract specimens (sputum, tracheal aspirates, BAL fluid) are more sensitive for detection of MERS-CoV by rRT-PCR testing than those from the upper respiratory tract (combined nasopharyngeal and throat swab, nasopharyngeal aspirates) [<a href="#rid8">8,10,14-16,55,58-60</a>]. However, upper respiratory tract specimens are still useful for diagnosing MERS-CoV. As an example, in a series of 47 patients with MERS-CoV, the majority of patients were diagnosed using nasopharyngeal swabs [<a href="#rid17">17</a>].</p><p>In a study of 37 patients with MERS-CoV infection in Saudi Arabia, lower respiratory tract specimens yielded the highest virus loads and were the most likely to be positive [<a href="#rid60">60</a>]. Of 199 lower respiratory tract samples collected during the first three weeks following diagnosis, 93 percent of tests yielded viral RNA; the average viral load was 5×10<sup>6</sup> copies/mL and the maximum viral load was 6×10<sup>10</sup> copies/mL. Of 84 upper respiratory tract specimens (throat swabs), 48 percent were positive. Of 108 serum samples tested, 33 percent yielded viral RNA, almost all during the first eight days after diagnosis. Only 15 percent of stool and 2 percent of urine samples yielded viral RNA.</p><p>In the same study, the average lower respiratory tract virus load during the first week after diagnosis was significantly higher in fatal cases than in nonfatal cases (5×10<sup>7</sup> versus 3.9×10<sup>6</sup> copies/mL) [<a href="#rid60">60</a>]. Another study found an association between higher virus load of MERS-CoV in the upper respiratory tract and worse clinical outcomes, including death and admission to the intensive care unit [<a href="#rid61">61</a>].</p><p>Three rRT-PCR assays for routine detection of MERS-CoV have been developed [<a href="#rid8">8</a>]. Currently described tests are an assay targeting a region upstream of the E protein gene (<em>upE</em>) [<a href="#rid58">58</a>] and assays targeting the open reading frame 1b (ORF 1b) [<a href="#rid58">58</a>] and the open reading frame 1a (ORF 1a) [<a href="#rid62">62</a>]. In some cases, sequencing should be performed for confirmation.</p><p>An emergency use authorization was issued by the US Food and Drug Administration in 2013 for the rRT-PCR assay developed by the CDC on clinical respiratory, blood, and stool samples [<a href="#rid63">63</a>].</p><p class="headingAnchor" id="H2743675046"><span class="h3">Serology</span><span class="headingEndMark"> — </span>Several serology assays have been developed for the detection of MERS-CoV antibodies, including immunofluorescence assays and a protein microarray assay [<a href="#rid8">8,62,64-66</a>]. The CDC has developed a two-stage approach, which uses an enzyme-linked immunosorbent assay (ELISA) for screening followed by an indirect immunofluorescence test or microneutralization test for confirmation [<a href="#rid8">8</a>]. Any positive test by a single serologic assay should be confirmed with a neutralization assay. There are limited data on the sensitivity and specificity of antibody tests for MERS-CoV.</p><p>According to the WHO, cases with a positive serologic test in the absence of PCR testing or sequencing are considered probable cases if they meet the other elements comprising the case definition of a probable case [<a href="#rid8">8</a>]. (See <a class="local">'Case definitions'</a> above.)</p><p>In a study of 37 patients with MERS-CoV infection in Saudi Arabia, all seroconversions occurred during the first two weeks following diagnosis, which corresponds to the second and third week after symptom onset [<a href="#rid60">60</a>]. All surviving patients, but only slightly more than half of the fatal cases, developed immunoglobulin (Ig)G and neutralizing antibodies. IgG and neutralizing antibody concentrations were weakly and inversely correlated with lower respiratory tract virus loads. In a study of 42 individuals in South Korea, all of whom had MERS-CoV detected by PCR from respiratory samples, none of 3 asymptomatic individuals developed neutralizing antibodies, whereas 3 of 5 with symptoms but without pneumonia, 15 of 16 with pneumonia but without respiratory failure, and all 9 with pneumonia with respiratory failure developed neutralizing antibodies [<a href="#rid67">67</a>].</p><p class="headingAnchor" id="H616795503"><span class="h2">Whom to test</span><span class="headingEndMark"> — </span>The WHO and the CDC have developed recommendations regarding whom to test. Clinicians in countries other than the United States should use the WHO's recommendations and consult with their ministry of health for further guidance regarding the evaluation of possible new cases of MERS-CoV infection.</p><p class="headingAnchor" id="H2239974106"><span class="h3">Outside the United States</span><span class="headingEndMark"> — </span>Based upon guidelines from the WHO, we recommend that, outside the United States, the following individuals be tested for MERS-CoV [<a href="#rid55">55</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>A person with an acute respiratory infection, which may include history of fever and cough and evidence of pulmonary parenchymal disease (eg, pneumonia or acute respiratory distress syndrome [ARDS]), based upon clinical or radiographic evidence of consolidation, who requires admission to hospital, with no other etiology that fully explains the clinical presentation. Testing should be performed according to local guidance for the evaluation of community-acquired pneumonia (CAP). Examples of other etiologies of CAP include <em>Streptococcus pneumoniae</em>, <em>Haemophilus influenzae</em> type b, <em>Legionella pneumophila</em>, other recognized causes of bacterial pneumonia, influenza, and respiratory syncytial virus. Clinicians should be alert to the possibility of atypical presentations in patients who are immunocompromised.</p><p></p><p class="bulletIndent1"><strong>AND</strong> any of the following:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>The person resides in the Middle East, particularly in regions where human MERS-CoV infections have been reported or in countries where MERS-CoV is known to be circulating in dromedary camels.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>The disease is in a cluster that occurs within a 14-day period, without regard to place of residence or history of travel. A cluster is defined as two or more persons with onset of symptoms within the same 14-day period associated with a specific setting, such as a classroom, workplace, household, extended family, hospital, other residential institution, military barracks, or recreational camp. (See  <a class="medical medical_review" href="/d/html/7032.html" rel="external">"Clinical evaluation and diagnostic testing for community-acquired pneumonia in adults"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>The disease occurs in a healthcare worker who has been working in an environment where patients with severe acute respiratory infections are being cared for, particularly patients requiring intensive care, without regard to place of residence or history of travel.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>The person has history of travel within 14 days before onset of illness to the Middle East or to countries where MERS-CoV is known to be circulating in dromedary camels or to regions where human cases have recently occurred.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>The person has an unusual or unexpected clinical course, especially sudden deterioration despite appropriate treatment, without regard to place of residence or history of travel, even if another etiology has been identified that fully explains the clinical presentation.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>An individual with an acute respiratory illness of any severity who, within 14 days of onset of illness, had any of the following exposures:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Close physical contact with a confirmed or probable case of MERS-CoV infection while that patient was ill. (See <a class="local">'Case definitions'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Exposure to a healthcare facility in a country where hospital-associated MERS-CoV infections have been reported.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Direct contact with dromedary camels or consumption or exposure to dromedary camel products (raw meat, unpasteurized milk, urine) in countries where MERS-CoV is known to be circulating in dromedary camel populations or where human infections occurred as a result of presumed zoonotic transmission.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Countries in the Middle East are strongly encouraged to consider adding testing for MERS-CoV to testing algorithms as part of routine sentinel respiratory disease surveillance and diagnostic panels for pneumonia.</p><p></p><p>Routine testing of asymptomatic contacts of cases is not recommended [<a href="#rid8">8</a>].</p><p class="headingAnchor" id="H3207359990"><span class="h3">In the United States</span><span class="headingEndMark"> — </span>The following discussion has been adapted from recommendations issued by the CDC for the investigation of possible cases in the United States [<a href="#rid57">57,68</a>].</p><p>Healthcare providers should evaluate individuals for MERS-CoV infection if they meet the following criteria for being a <strong>patient under investigation</strong> [<a href="#rid68">68</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Fever <strong>and</strong> pneumonia or acute respiratory distress syndrome (based on clinical or radiographic evidence) <strong>and</strong> <strong>either</strong>:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>A history of travel from countries in or near the Arabian Peninsula (countries considered in or neighboring the Arabian Peninsula include Bahrain, Iraq, Iran, Israel, Jordan, Kuwait, Lebanon, Oman, Palestinian territories, Qatar, Saudi Arabia, Syria, the United Arab Emirates, and Yemen) within 14 days before symptom onset <strong>or</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Close contact with a symptomatic traveler who developed fever and acute respiratory illness (not necessarily pneumonia) within 14 days after traveling from countries in or near the Arabian Peninsula <strong>or</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>A history of being in a healthcare facility (as a patient, worker, or visitor) in South Korea within 14 days before symptom onset <strong>or</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Is a member of a cluster of patients with severe acute respiratory illness (eg, fever and pneumonia requiring hospitalization) of unknown etiology in which MERS-CoV is being evaluated in consultation with state and local health departments</p><p></p><p class="bulletIndent1"><strong>OR</strong></p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Fever and symptoms of respiratory illness (eg, cough, shortness of breath) and being in a healthcare facility (as a patient, healthcare worker, or visitor) within 14 days before symptom onset in a country in or near the Arabian Peninsula in which recent healthcare-associated cases of MERS-CoV have been identified</p><p></p><p class="bulletIndent1"><strong>OR</strong></p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Fever <strong>or</strong> symptoms of respiratory illness (eg, cough, shortness of breath) and close contact with a confirmed MERS-CoV case while the affected person was ill</p><p></p><p>A <strong>close contact</strong> is defined as [<a href="#rid68">68</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Being within approximately 6 feet (2 meters) or within the room or care area for a prolonged period of time (eg, healthcare personnel, household members) while not wearing recommended personal protective equipment (ie, gowns, gloves, respirator, eye protection)</p><p></p><p class="bulletIndent1"><strong>OR</strong></p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Having direct contact with infectious secretions (eg, being coughed on) while not wearing recommended personal protective equipment (ie, gowns, gloves, respirator, eye protection)</p><p></p><p>Additional information can be found on the <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.cdc.gov%2Fcoronavirus%2Fmers%2Finterim-guidance.html&amp;token=faGC%2FLAA7hI5mETFZnfZlKcAd8LlITHvgC37HnzH0jhHdwlk%2Fqcp82M%2BLlVAiMNhYkzzmp5DHjTkf95ezuSO6w%3D%3D&amp;TOPIC_ID=106589" target="_blank">CDC's website</a>.</p><p>The CDC requests that state and local health departments immediately report patients under investigation for MERS-CoV infection to the CDC.</p><p class="headingAnchor" id="H1885905088"><span class="h2">Specimen handling</span><span class="headingEndMark"> — </span>Specimens should reach the laboratory as soon as possible after collection [<a href="#rid8">8</a>]. When there is likely to be a delay of more than 72 hours in the laboratory receiving respiratory tract specimens, specimens should be frozen at -80°C and shipped on dry ice. It is important to avoid repeated freezing and thawing of specimens. Serum should be separated from whole blood and can be stored and shipped at 4°C or frozen and shipped on dry ice or liquid nitrogen. Storage of respiratory and serum specimens in domestic frost-free freezers should be avoided, given their wide temperature fluctuations.</p><p class="headingAnchor" id="H1626352107"><span class="h2">Where to ship specimens</span><span class="headingEndMark"> — </span>For patients in the United States, clinicians seeking information about shipping or testing should contact the CDC Emergency Operations Center at 770-488-7100. Additional information can be found on the <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.cdc.gov%2Fcoronavirus%2Fmers%2Finterim-guidance.html&amp;token=faGC%2FLAA7hI5mETFZnfZlKcAd8LlITHvgC37HnzH0jhHdwlk%2Fqcp82M%2BLlVAiMNhYkzzmp5DHjTkf95ezuSO6w%3D%3D&amp;TOPIC_ID=106589" target="_blank">CDC's website</a>.</p><p>For patients in countries other than the United States, clinicians should follow the recommendations of their ministry of health regarding diagnostic testing.</p><p class="headingAnchor" id="H777756529"><span class="h2">Reporting cases</span><span class="headingEndMark"> — </span>The WHO recommends that probable and confirmed cases be reported within 24 hours of classification through the Regional Contact Point for International Health Regulations at the appropriate WHO Regional Office [<a href="#rid55">55</a>]. (See <a class="local">'Case definitions'</a> above.)</p><p>Additional recommendations regarding reporting of MERS-CoV infections can be found on the <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.who.int%2Fhealth-topics%2Fmiddle-east-respiratory-syndrome-coronavirus-mers%23tab%3Dtab_1&amp;token=%2FPi1VLB9%2BfHsXlMtDZzxAbI5gdR%2FzRnOgz42K%2FJDpD9STtBJXXEOEo3Bwzg3uFxMHGhhPh7vvpTLbblcEAu3ki10n%2BpvnrmMRNMpCMcRzx5V28Nktvhr1giztMlF4WOy&amp;TOPIC_ID=106589" target="_blank">WHO's website</a> and the <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.cdc.gov%2Fcoronavirus%2Fmers%2Finterim-guidance.html&amp;token=faGC%2FLAA7hI5mETFZnfZlKcAd8LlITHvgC37HnzH0jhHdwlk%2Fqcp82M%2BLlVAiMNhYkzzmp5DHjTkf95ezuSO6w%3D%3D&amp;TOPIC_ID=106589" target="_blank">CDC's website</a>.</p><p class="headingAnchor" id="H2708898960"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/126619.html" rel="external">"Society guideline links: Middle East respiratory syndrome coronavirus"</a>.)</p><p class="headingAnchor" id="H1521273369"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)</p><p class="bulletIndent1"><span class="glyph">●</span>Basics topic (see  <a class="medical medical_basics" href="/d/html/95040.html" rel="external">"Patient education: Middle East respiratory syndrome coronavirus (The Basics)"</a>)</p><p></p><p class="headingAnchor" id="H16517238"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical features</strong> – Most reported patients with Middle East respiratory syndrome coronavirus (MERS-CoV) infection have been adults with severe pneumonia and acute respiratory distress syndrome, and some have had acute kidney injury. Many patients have required mechanical ventilation, and some have required extracorporeal membrane oxygenation. Other clinical manifestations that have been reported are gastrointestinal symptoms (anorexia, nausea, vomiting, abdominal pain, diarrhea), pericarditis, and disseminated intravascular coagulation. Frequency and severity of symptoms are directly proportional to age. (See <a class="local">'Clinical features'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Incubation period</strong> – Based on limited data, the median incubation period of MERS-CoV is an estimated 5 days with a range of 2 to 15 days. (See <a class="local">'Incubation period'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>When to suspect MERS-CoV</strong> – Individuals with an acute respiratory infection who have an epidemiologic link to MERS-CoV (eg, relevant residence or travel history, potential exposure to known or suspected case or cluster) or who have had an unusual or unexpected clinical course (especially sudden deterioration despite appropriate treatment) should be tested for MERS-CoV. Certain other patients may also warrant evaluation for MERS-CoV infection. Specific recommendations regarding whom to test are presented above. (See <a class="local">'Whom to test'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Microbiologic diagnosis</strong> – Real-time reverse-transcriptase polymerase chain reaction (rRT-PCR) testing applied to respiratory secretions is the diagnostic assay of choice. Ideally, lower respiratory tract, upper respiratory tract, <strong>and</strong> serum samples should be obtained. Lower respiratory tract specimens should be a priority for collection and testing. To increase the likelihood of detecting MERS-CoV, we suggest collection of multiple specimens from different sites and at different times. (See <a class="local">'Diagnosis'</a> above and <a class="local">'Preferred tests and specimen types'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Case reporting</strong> – The World Health Organization (WHO) recommends that probable and confirmed cases be reported within 24 hours of classification through the Regional Contact Point for International Health Regulations at the appropriate WHO Regional Office. (See <a class="local">'Reporting cases'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>WHO and CDC links</strong> – Additional information about MERS-CoV can be found on the <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.who.int%2Fhealth-topics%2Fmiddle-east-respiratory-syndrome-coronavirus-mers&amp;token=DUCwvOXI65XPQY65WI07JcE4ldjYN0PAkEUOBQzptFTTrhhEJkccWdMeM3sEbUVYFxKOEM57Q7IQB0d4ShIIP0wcA5IRpiE7nlvq%2FH9XP9k%3D&amp;TOPIC_ID=106589" target="_blank">World Health Organization (WHO) website</a> and the <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.cdc.gov%2Fcoronavirus%2Fmers%2Findex.html&amp;token=R4Uiw8%2FbmPVaqNHRDqpXLETVYV9fJcW0p5%2FSZ3txP%2BFbcePMPPOiI3FXSckc6d4vCKD86AbmnZK0tsD4HZ1lxQ%3D%3D&amp;TOPIC_ID=106589" target="_blank">Centers for Disease Control and Prevention (CDC) website</a>.</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li class="breakAll">ProMed Mail: Novel coronavirus - Saudi Arabia: human isolate; Archive Number: 20120920.1302733 http://www.promedmail.org/direct.php?id=20120920.1302733 (Accessed on April 22, 2013).</li><li class="breakAll">World Health Organization. Novel coronavirus infection in the United Kingdom. http://www.who.int/csr/don/2012_09_23/en/index.html (Accessed on September 25, 2012).</li><li><a class="nounderline abstract_t">Wise J. Patient with new strain of coronavirus is treated in intensive care at London hospital. BMJ 2012; 345:e6455.</a></li><li><a class="nounderline abstract_t">Zaki AM, van Boheemen S, Bestebroer TM, et al. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med 2012; 367:1814.</a></li><li><a class="nounderline abstract_t">Memish ZA, Perlman S, Van Kerkhove MD, Zumla A. Middle East respiratory syndrome. Lancet 2020; 395:1063.</a></li><li><a class="nounderline abstract_t">de Groot RJ, Baker SC, Baric RS, et al. Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group. J Virol 2013; 87:7790.</a></li><li class="breakAll">World Health Organization. Revised case definition for reporting to WHO – Middle East respiratory syndrome coronavirus - Interim case definition as of 14 July 2015. http://www.who.int/csr/disease/coronavirus_infections/case_definition/en/ (Accessed on June 19, 2017).</li><li class="breakAll">World Health Organization. Laboratory testing for Middle East respiratory syndrome coronavirus - Interim recommendations (revised), January 2018. http://www.who.int/csr/disease/coronavirus_infections/WHO_interim_recommendations_lab_detection_MERSCoV_092014.pdf?ua=1 (Accessed on December 01, 2020).</li><li><a class="nounderline abstract_t">Assiri A, McGeer A, Perl TM, et al. Hospital outbreak of Middle East respiratory syndrome coronavirus. N Engl J Med 2013; 369:407.</a></li><li><a class="nounderline abstract_t">Guery B, Poissy J, el Mansouf L, et al. Clinical features and viral diagnosis of two cases of infection with Middle East Respiratory Syndrome coronavirus: a report of nosocomial transmission. Lancet 2013; 381:2265.</a></li><li><a class="nounderline abstract_t">Cowling BJ, Park M, Fang VJ, et al. Preliminary epidemiological assessment of MERS-CoV outbreak in South Korea, May to June 2015. Euro Surveill 2015; 20:7.</a></li><li><a class="nounderline abstract_t">Virlogeux V, Fang VJ, Park M, et al. Comparison of incubation period distribution of human infections with MERS-CoV in South Korea and Saudi Arabia. Sci Rep 2016; 6:35839.</a></li><li><a class="nounderline abstract_t">Centers for Disease Control and Prevention (CDC). Update: Severe respiratory illness associated with Middle East Respiratory Syndrome Coronavirus (MERS-CoV)--worldwide, 2012-2013. MMWR Morb Mortal Wkly Rep 2013; 62:480.</a></li><li><a class="nounderline abstract_t">Memish ZA, Zumla AI, Al-Hakeem RF, et al. Family cluster of Middle East respiratory syndrome coronavirus infections. N Engl J Med 2013; 368:2487.</a></li><li class="breakAll">World Health Organization. Novel coronavirus summary and literature update – as of 17 May 2013. http://www.who.int/csr/disease/coronavirus_infections/update_20130517/en/index.html# (Accessed on May 17, 2013).</li><li><a class="nounderline abstract_t">Drosten C, Seilmaier M, Corman VM, et al. Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection. Lancet Infect Dis 2013; 13:745.</a></li><li><a class="nounderline abstract_t">Assiri A, Al-Tawfiq JA, Al-Rabeeah AA, et al. Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study. Lancet Infect Dis 2013; 13:752.</a></li><li><a class="nounderline abstract_t">Arabi YM, Arifi AA, Balkhy HH, et al. Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection. Ann Intern Med 2014; 160:389.</a></li><li><a class="nounderline abstract_t">Arabi YM, Balkhy HH, Hayden FG, et al. Middle East Respiratory Syndrome. N Engl J Med 2017; 376:584.</a></li><li><a class="nounderline abstract_t">Arabi YM, Al-Omari A, Mandourah Y, et al. Critically Ill Patients With the Middle East Respiratory Syndrome: A Multicenter Retrospective Cohort Study. Crit Care Med 2017; 45:1683.</a></li><li class="breakAll">World Health Organization. Background and summary of novel coronavirus infection – as of 21 December 2012. http://www.who.int/csr/disease/coronavirus_infections/update_20121221/en/index.html (Accessed on February 12, 2013).</li><li><a class="nounderline abstract_t">Bak SL, Jun KI, Jung J, et al. An Atypical Case of Middle East Respiratory Syndrome in a Returning Traveler to Korea from Kuwait, 2018. J Korean Med Sci 2018; 33:e348.</a></li><li><a class="nounderline abstract_t">Arabi YM, Harthi A, Hussein J, et al. Severe neurologic syndrome associated with Middle East respiratory syndrome corona virus (MERS-CoV). Infection 2015; 43:495.</a></li><li><a class="nounderline abstract_t">Memish ZA, Zumla AI, Assiri A. Middle East respiratory syndrome coronavirus infections in health care workers. N Engl J Med 2013; 369:884.</a></li><li><a class="nounderline abstract_t">Kapoor M, Pringle K, Kumar A, et al. Clinical and laboratory findings of the first imported case of Middle East respiratory syndrome coronavirus to the United States. Clin Infect Dis 2014; 59:1511.</a></li><li class="breakAll">World Health Organization. Middle East respiratory syndrome coronavirus (MERS-CoV): Summary of current situation, literature update and risk assessment–as of 5 February 2015. http://www.who.int/csr/disease/coronavirus_infections/mers-5-february-2015.pdf?ua=1 (Accessed on March 04, 2015).</li><li><a class="nounderline abstract_t">Oboho IK, Tomczyk SM, Al-Asmari AM, et al. 2014 MERS-CoV outbreak in Jeddah--a link to health care facilities. N Engl J Med 2015; 372:846.</a></li><li><a class="nounderline abstract_t">Drosten C, Meyer B, Müller MA, et al. Transmission of MERS-coronavirus in household contacts. N Engl J Med 2014; 371:828.</a></li><li><a class="nounderline abstract_t">Lessler J, Salje H, Van Kerkhove MD, et al. Estimating the Severity and Subclinical Burden of Middle East Respiratory Syndrome Coronavirus Infection in the Kingdom of Saudi Arabia. Am J Epidemiol 2016; 183:657.</a></li><li><a class="nounderline abstract_t">Al Hammadi ZM, Chu DK, Eltahir YM, et al. Asymptomatic MERS-CoV Infection in Humans Possibly Linked to Infected Dromedaries Imported from Oman to United Arab Emirates, May 2015. Emerg Infect Dis 2015; 21:2197.</a></li><li><a class="nounderline abstract_t">Al-Tawfiq JA, Kattan RF, Memish ZA. Middle East respiratory syndrome coronavirus disease is rare in children: An update from Saudi Arabia. World J Clin Pediatr 2016; 5:391.</a></li><li><a class="nounderline abstract_t">Memish ZA, Al-Tawfiq JA, Assiri A, et al. Middle East respiratory syndrome coronavirus disease in children. Pediatr Infect Dis J 2014; 33:904.</a></li><li><a class="nounderline abstract_t">Thabet F, Chehab M, Bafaqih H, Al Mohaimeed S. Middle East respiratory syndrome coronavirus in children. Saudi Med J 2015; 36:484.</a></li><li><a class="nounderline abstract_t">Alfaraj SH, Al-Tawfiq JA, Memish ZA. Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection during pregnancy: Report of two cases &amp; review of the literature. J Microbiol Immunol Infect 2019; 52:501.</a></li><li><a class="nounderline abstract_t">Mullins E, Evans D, Viner RM, et al. Coronavirus in pregnancy and delivery: rapid review. Ultrasound Obstet Gynecol 2020; 55:586.</a></li><li><a class="nounderline abstract_t">Payne DC, Iblan I, Alqasrawi S, et al. Stillbirth during infection with Middle East respiratory syndrome coronavirus. J Infect Dis 2014; 209:1870.</a></li><li><a class="nounderline abstract_t">Malik A, El Masry KM, Ravi M, Sayed F. Middle East Respiratory Syndrome Coronavirus during Pregnancy, Abu Dhabi, United Arab Emirates, 2013. Emerg Infect Dis 2016; 22:515.</a></li><li><a class="nounderline abstract_t">Alserehi H, Wali G, Alshukairi A, Alraddadi B. Impact of Middle East Respiratory Syndrome coronavirus (MERS-CoV) on pregnancy and perinatal outcome. BMC Infect Dis 2016; 16:105.</a></li><li><a class="nounderline abstract_t">Assiri A, Abedi GR, Al Masri M, et al. Middle East Respiratory Syndrome Coronavirus Infection During Pregnancy: A Report of 5 Cases From Saudi Arabia. Clin Infect Dis 2016; 63:951.</a></li><li><a class="nounderline abstract_t">Park MH, Kim HR, Choi DH, et al. Emergency cesarean section in an epidemic of the middle east respiratory syndrome: a case report. Korean J Anesthesiol 2016; 69:287.</a></li><li><a class="nounderline abstract_t">Jeong SY, Sung SI, Sung JH, et al. MERS-CoV Infection in a Pregnant Woman in Korea. J Korean Med Sci 2017; 32:1717.</a></li><li><a class="nounderline abstract_t">Bermingham A, Chand MA, Brown CS, et al. Severe respiratory illness caused by a novel coronavirus, in a patient transferred to the United Kingdom from the Middle East, September 2012. Euro Surveill 2012; 17:20290.</a></li><li><a class="nounderline abstract_t">Das KM, Lee EY, Al Jawder SE, et al. Acute Middle East Respiratory Syndrome Coronavirus: Temporal Lung Changes Observed on the Chest Radiographs of 55 Patients. AJR Am J Roentgenol 2015; 205:W267.</a></li><li><a class="nounderline abstract_t">Ajlan AM, Ahyad RA, Jamjoom LG, et al. Middle East respiratory syndrome coronavirus (MERS-CoV) infection: chest CT findings. AJR Am J Roentgenol 2014; 203:782.</a></li><li><a class="nounderline abstract_t">Das KM, Lee EY, Enani MA, et al. CT correlation with outcomes in 15 patients with acute Middle East respiratory syndrome coronavirus. AJR Am J Roentgenol 2015; 204:736.</a></li><li><a class="nounderline abstract_t">Das KM, Lee EY, Langer RD, Larsson SG. Middle East Respiratory Syndrome Coronavirus: What Does a Radiologist Need to Know? AJR Am J Roentgenol 2016; 206:1193.</a></li><li><a class="nounderline abstract_t">Centers for Disease Control and Prevention (CDC). Updated information on the epidemiology of Middle East respiratory syndrome coronavirus (MERS-CoV) infection and guidance for the public, clinicians, and public health authorities, 2012-2013. MMWR Morb Mortal Wkly Rep 2013; 62:793.</a></li><li><a class="nounderline abstract_t">Badawi A, Ryoo SG. Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis. Int J Infect Dis 2016; 49:129.</a></li><li><a class="nounderline abstract_t">Drosten C. Is MERS another SARS? Lancet Infect Dis 2013; 13:727.</a></li><li><a class="nounderline abstract_t">Kim KH, Tandi TE, Choi JW, et al. Middle East respiratory syndrome coronavirus (MERS-CoV) outbreak in South Korea, 2015: epidemiology, characteristics and public health implications. J Hosp Infect 2017; 95:207.</a></li><li><a class="nounderline abstract_t">Alraddadi BM, Watson JT, Almarashi A, et al. Risk Factors for Primary Middle East Respiratory Syndrome Coronavirus Illness in Humans, Saudi Arabia, 2014. Emerg Infect Dis 2016; 22:49.</a></li><li><a class="nounderline abstract_t">Meyerholz DK, Lambertz AM, McCray PB Jr. Dipeptidyl Peptidase 4 Distribution in the Human Respiratory Tract: Implications for the Middle East Respiratory Syndrome. Am J Pathol 2016; 186:78.</a></li><li><a class="nounderline abstract_t">Seys LJM, Widagdo W, Verhamme FM, et al. DPP4, the Middle East Respiratory Syndrome Coronavirus Receptor, is Upregulated in Lungs of Smokers and Chronic Obstructive Pulmonary Disease Patients. Clin Infect Dis 2018; 66:45.</a></li><li class="breakAll">World Health Organization. Middle East respiratory syndrome coronavirus (MERS-CoV). Initial interview questionnaire of cases. http://www.who.int/csr/disease/coronavirus_infections/MERS_case_investigation_questionnaire.pdf (Accessed on August 13, 2013).</li><li class="breakAll">World Health Organization. Interim surveillance recommendations for human infection with Middle East respiratory syndrome coronavirus. http://www.who.int/csr/disease/coronavirus_infections/InterimRevisedSurveillanceRecommendations_nCoVinfection_14July2014.pdf?ua=1 (Accessed on March 23, 2015).</li><li class="breakAll">Centers for Disease Control and Prevention. Interim guidelines for collecting, handling, and testing clinical specimens from patients under investigation (PUIs) for Middle East respiratory syndrome coronavirus (MERS-CoV) – Version 2.1. http://www.cdc.gov/coronavirus/mers/guidelines-clinical-specimens.html (Accessed on June 17, 2015).</li><li><a class="nounderline abstract_t">Bialek SR, Allen D, Alvarado-Ramy F, et al. First confirmed cases of Middle East respiratory syndrome coronavirus (MERS-CoV) infection in the United States, updated information on the epidemiology of MERS-CoV infection, and guidance for the public, clinicians, and public health authorities - May 2014. MMWR Morb Mortal Wkly Rep 2014; 63:431.</a></li><li><a class="nounderline abstract_t">Corman VM, Eckerle I, Bleicker T, et al. Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction. Euro Surveill 2012; 17.</a></li><li><a class="nounderline abstract_t">Memish ZA, Al-Tawfiq JA, Makhdoom HQ, et al. Respiratory tract samples, viral load, and genome fraction yield in patients with Middle East respiratory syndrome. J Infect Dis 2014; 210:1590.</a></li><li><a class="nounderline abstract_t">Corman VM, Albarrak AM, Omrani AS, et al. Viral Shedding and Antibody Response in 37 Patients With Middle East Respiratory Syndrome Coronavirus Infection. Clin Infect Dis 2016; 62:477.</a></li><li><a class="nounderline abstract_t">Feikin DR, Alraddadi B, Qutub M, et al. Association of Higher MERS-CoV Virus Load with Severe Disease and Death, Saudi Arabia, 2014. Emerg Infect Dis 2015; 21:2029.</a></li><li><a class="nounderline abstract_t">Corman VM, Müller MA, Costabel U, et al. Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections. Euro Surveill 2012; 17.</a></li><li class="breakAll">US Food and Drug Administration. Letter of authorization: CDC novel coronavirus 2012 real-time RT-PCR assay. http://www.fda.gov/MedicalDevices/Safety/EmergencySituations/ucm355529.htm (Accessed on June 13, 2013).</li><li><a class="nounderline abstract_t">Chan KH, Chan JF, Tse H, et al. Cross-reactive antibodies in convalescent SARS patients' sera against the emerging novel human coronavirus EMC (2012) by both immunofluorescent and neutralizing antibody tests. J Infect 2013; 67:130.</a></li><li><a class="nounderline abstract_t">Buchholz U, Müller MA, Nitsche A, et al. Contact investigation of a case of human novel coronavirus infection treated in a German hospital, October-November 2012. Euro Surveill 2013; 18.</a></li><li><a class="nounderline abstract_t">Reusken C, Mou H, Godeke GJ, et al. Specific serology for emerging human coronaviruses by protein microarray. Euro Surveill 2013; 18:20441.</a></li><li><a class="nounderline abstract_t">Ko JH, Müller MA, Seok H, et al. Serologic responses of 42 MERS-coronavirus-infected patients according to the disease severity. Diagn Microbiol Infect Dis 2017; 89:106.</a></li><li class="breakAll">Centers for Disease Control and Prevention. Interim guidance for healthcare professionals. Patients in the U.S. who should be evaluated for MERS-CoV infection. http://www.cdc.gov/coronavirus/mers/interim-guidance.html (Accessed on June 17, 2015).</li></ol></div><div id="topicVersionRevision">Topic 106589 Version 23.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="http://www.promedmail.org/direct.php?id=20120920.1302733" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : ProMed Mail: Novel coronavirus - Saudi Arabia: human isolate; Archive Number: 20120920.1302733 http://www.promedmail.org/direct.php?id=20120920.1302733 (Accessed on April 22, 2013).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="http://www.who.int/csr/don/2012_09_23/en/index.html" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : World Health Organization. Novel coronavirus infection in the United Kingdom. http://www.who.int/csr/don/2012_09_23/en/index.html (Accessed on September 25, 2012).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23008211" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Patient with new strain of coronavirus is treated in intensive care at London hospital.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23075143" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32145185" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Middle East respiratory syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23678167" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23678167" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23678167" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23782161" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Hospital outbreak of Middle East respiratory syndrome coronavirus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23727167" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Clinical features and viral diagnosis of two cases of infection with Middle East Respiratory Syndrome coronavirus: a report of nosocomial transmission.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26132767" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Preliminary epidemiological assessment of MERS-CoV outbreak in South Korea, May to June 2015.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27775012" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Comparison of incubation period distribution of human infections with MERS-CoV in South Korea and Saudi Arabia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23760190" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Update: Severe respiratory illness associated with Middle East Respiratory Syndrome Coronavirus (MERS-CoV)--worldwide, 2012-2013.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23718156" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Family cluster of Middle East respiratory syndrome coronavirus infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23718156" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Family cluster of Middle East respiratory syndrome coronavirus infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23782859" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23891402" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24474051" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28177862" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Middle East Respiratory Syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28787295" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Critically Ill Patients With the Middle East Respiratory Syndrome: A Multicenter Retrospective Cohort Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28787295" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Critically Ill Patients With the Middle East Respiratory Syndrome: A Multicenter Retrospective Cohort Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30595687" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : An Atypical Case of Middle East Respiratory Syndrome in a Returning Traveler to Korea from Kuwait, 2018.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25600929" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Severe neurologic syndrome associated with Middle East respiratory syndrome corona virus (MERS-CoV).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23923992" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Middle East respiratory syndrome coronavirus infections in health care workers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25100864" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Clinical and laboratory findings of the first imported case of Middle East respiratory syndrome coronavirus to the United States.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25100864" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Clinical and laboratory findings of the first imported case of Middle East respiratory syndrome coronavirus to the United States.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25714162" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : 2014 MERS-CoV outbreak in Jeddah--a link to health care facilities.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25162889" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Transmission of MERS-coronavirus in household contacts.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26851269" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Estimating the Severity and Subclinical Burden of Middle East Respiratory Syndrome Coronavirus Infection in the Kingdom of Saudi Arabia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26584223" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Asymptomatic MERS-CoV Infection in Humans Possibly Linked to Infected Dromedaries Imported from Oman to United Arab Emirates, May 2015.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27872828" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Middle East respiratory syndrome coronavirus disease is rare in children: An update from Saudi Arabia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24763193" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Middle East respiratory syndrome coronavirus disease in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25828287" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Middle East respiratory syndrome coronavirus in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29907538" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection during pregnancy: Report of two cases&amp;review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32180292" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Coronavirus in pregnancy and delivery: rapid review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24474813" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Stillbirth during infection with Middle East respiratory syndrome coronavirus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26890613" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Middle East Respiratory Syndrome Coronavirus during Pregnancy, Abu Dhabi, United Arab Emirates, 2013.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26936356" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Impact of Middle East Respiratory Syndrome coronavirus (MERS-CoV) on pregnancy and perinatal outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27358348" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Middle East Respiratory Syndrome Coronavirus Infection During Pregnancy: A Report of 5 Cases From Saudi Arabia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27274377" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Emergency cesarean section in an epidemic of the middle east respiratory syndrome: a case report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28875620" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : MERS-CoV Infection in a Pregnant Woman in Korea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23078800" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Severe respiratory illness caused by a novel coronavirus, in a patient transferred to the United Kingdom from the Middle East, September 2012.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26102309" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Acute Middle East Respiratory Syndrome Coronavirus: Temporal Lung Changes Observed on the Chest Radiographs of 55 Patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24918624" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Middle East respiratory syndrome coronavirus (MERS-CoV) infection: chest CT findings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25615627" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : CT correlation with outcomes in 15 patients with acute Middle East respiratory syndrome coronavirus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26998804" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Middle East Respiratory Syndrome Coronavirus: What Does a Radiologist Need to Know?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24067584" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Updated information on the epidemiology of Middle East respiratory syndrome coronavirus (MERS-CoV) infection and guidance for the public, clinicians, and public health authorities, 2012-2013.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27352628" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23891403" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Is MERS another SARS?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28153558" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Middle East respiratory syndrome coronavirus (MERS-CoV) outbreak in South Korea, 2015: epidemiology, characteristics and public health implications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26692185" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Risk Factors for Primary Middle East Respiratory Syndrome Coronavirus Illness in Humans, Saudi Arabia, 2014.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26597880" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Dipeptidyl Peptidase 4 Distribution in the Human Respiratory Tract: Implications for the Middle East Respiratory Syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29020176" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : DPP4, the Middle East Respiratory Syndrome Coronavirus Receptor, is Upregulated in Lungs of Smokers and Chronic Obstructive Pulmonary Disease Patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29020176" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : DPP4, the Middle East Respiratory Syndrome Coronavirus Receptor, is Upregulated in Lungs of Smokers and Chronic Obstructive Pulmonary Disease Patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29020176" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : DPP4, the Middle East Respiratory Syndrome Coronavirus Receptor, is Upregulated in Lungs of Smokers and Chronic Obstructive Pulmonary Disease Patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29020176" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : DPP4, the Middle East Respiratory Syndrome Coronavirus Receptor, is Upregulated in Lungs of Smokers and Chronic Obstructive Pulmonary Disease Patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24827411" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : First confirmed cases of Middle East respiratory syndrome coronavirus (MERS-CoV) infection in the United States, updated information on the epidemiology of MERS-CoV infection, and guidance for the public, clinicians, and public health authorities - May 2014.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23041020" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24837403" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Respiratory tract samples, viral load, and genome fraction yield in patients with Middle East respiratory syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26565003" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Viral Shedding and Antibody Response in 37 Patients With Middle East Respiratory Syndrome Coronavirus Infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26488195" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Association of Higher MERS-CoV Virus Load with Severe Disease and Death, Saudi Arabia, 2014.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23231891" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23231891" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23583636" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Cross-reactive antibodies in convalescent SARS patients' sera against the emerging novel human coronavirus EMC (2012) by both immunofluorescent and neutralizing antibody tests.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23449231" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Contact investigation of a case of human novel coronavirus infection treated in a German hospital, October-November 2012.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23594517" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Specific serology for emerging human coronaviruses by protein microarray.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28821364" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Serologic responses of 42 MERS-coronavirus-infected patients according to the disease severity.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
